New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News For AAPL;JPM;RDSA;NVS;BKS;WDC;GD;VIA;VIAB;BLK;MPC From The Last 14 Days
Check below for free stories on AAPL;JPM;RDSA;NVS;BKS;WDC;GD;VIA;VIAB;BLK;MPC the last two weeks.
Sign up for a free trial to see the rest of the stories you've been missing.
<< 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | all recent news | >>
April 15, 2014
08:54 EDTBLKBlackRock April volatility elevated at 38 into Q4 and outlook
Subscribe for More Information
07:51 EDTGDGeneral Dynamics chooses to skip GAO protest over Army car plan, Reuters says
General Dynamics (GD) said it would not ask the congressional Government Accountability Office to rule on a U.S. Army vehicle competition that it says is skewed to favor its rival, Britain's BAE Systems (BAESY), according to Reuters, citing a statement from a General Dynamics spokesman. The spokesman said, "We will continue to discuss the AMPV program with the U.S. Department of Defense and the Congress. We do not believe a GAO protest is the right forum for this issue and we will not file one." Reference Link
07:46 EDTAAPLMonitor says Apple antitrust compliance off to 'promising start,' Reuters says
Subscribe for More Information
07:35 EDTNVSAlnylam outlook not affected by Novartis decision, says JMP Securities
Subscribe for More Information
07:28 EDTBLKSEC officials weighing curbs on trading fees, WSJ says
SEC officials, including some commissioners, are considering a trial program to curb "maker-taker" fee plans that are a major source of revenue for exchanges and some high-frequency trading firms, according to The Wall Street Journal. Fund managers, including BlackRock (BLK), are concerned about the negative effects of maker-taker, the report added. IntercontinentalExchange (ICE) CEO Jeffrey Sprecher, along with representatives from T. Rowe Price (TROW) and from RBC Capital (RY), recently held a series of private meetings with SEC Chairman Mary Jo White to push for its elimination, according to the report, citing people familiar with the matter. Like IntercontinentalExchange, which owns the New York Stock Exchange, Nasdaq (NDAQ) is a publicly-traded exchange operator. Reference Link
07:22 EDTNVSNovartis to Shire said to mull offers for ThromboGenics, Bloomberg says
Subscribe for More Information
06:36 EDTNVSRanbaxy inspection failures add $900M to heart drug costs, Bloomberg says
A gap in U.S. patent law has kept cheap copies of Novartis' (NVS) heart drug Diovan off the market for 18 months, which has cost U.S. consumers and insurers as much as $900M in possible savings, reported Bloomberg. Ranbaxy (RBXLY) is the only company permitted to sell a generic version of Diovan, and hasnít been able to manufacture and market them after four factories it runs in India failed U.S. inspections. Reference Link
06:32 EDTNVSPatients paying much more for specialty drugs, NY Times says
The amount that patients with certain diseases must pay for specialty drugs has increased significantly, a research firm reported, according to The New York Times. Meanwhile, consumers' use of health care increased in 2013 for the firm time in three years, the newspaper quoted the firm, the IMS Institute for Healthcare Informatics, as saying. Publicly traded drug makers include AstraZeneca (AZN), Bristol-Myers (BMY), Eli Lilly (LLY), GlaxoSmithKline (GSK), Johnson & Johnson (JNJ), Merck (MRK), Novartis (NVS), Pfizer (PFE), Roche (RHHBY) and Sanofi (SNY). Publicly traded health insurers include AMERIGROUP (AGP), Aetna (AET), Centene (CNC), Cigna (CI), Health Net (HNT), Healthspring (HS), Humana (HUM), Molina Healthcare (MOH), UnitedHealth (UNH), WellCare (WCG) and WellPoint (WLP).Reference Link
06:08 EDTAAPLSamsung: Gains in smartphone market the result of strategy shift, WSJ reports
Subscribe for More Information
April 14, 2014
16:00 EDTAAPLOptions Update; April 14, 2014
iPath S&P 500 VIX Short-Term Futures down 32c to 44.41. Option volume leaders: AAPL C GILD TSLA LNG NQ BAC ZNGA according to Track Data.
14:42 EDTNVSAlnylam slips after Novartis reportedly cuts back RNAi development
Subscribe for More Information
11:48 EDTNVSNovartis significantly reducing RNAi development efforts, FierceBiotech says
Subscribe for More Information
10:56 EDTJPMMasterCard, Visa rise after analysts recommend their shares
Subscribe for More Information
10:03 EDTGDGeneral Dynamics Canada to provide sonar system upgrades to Portuguese Navy
General Dynamics Canada is installing an adjunct processing system on three VASCO DA GAMA-class frigates of the Portuguese Navy. Designed by General Dynamics Canada, the ECLIPSE adjunct processor provides the in-service AN/SQS-510 sonar systems with enhanced operational capability to detect submarines and torpedoes.
09:36 EDTAAPLActive equity options trading on open
Subscribe for More Information
09:05 EDTJPMJPMorgan valuation still attractive, says Wells Fargo
Subscribe for More Information
07:54 EDTAAPLApple in talks for $100 iPhone 6 price increase, says Jefferies
Subscribe for More Information
07:08 EDTJPMJPMorgan has good value for patient investors, says Bernstein
After JPMorgan reported weaker than expected Q1 results, Bernstein reduced its 2014 EPS estimate for the company to $5.50 from $5.80. However, the firm thinks the company could benefit from higher interest rates, while its valuation is attractive. Bernstein keeps an Outperform rating on the stock.
07:06 EDTAAPLU.S. Geospatial Intelligence Foundation to hold a symposium
GEOINT 2013 Symposium, originally scheduled for October 2013, is being held in Tampa, Florida on April 14-17.
06:50 EDTAAPLChecks show Apple not developing basebands, says Deutsche Bank
Deutsche Bank says that despite recent press reports, its industry checks show that Apple (AAPL) is not developing its own baseband chipset. Deutsche believes Apple likely seeking better integration with existing baseband chipsets or possibly developing its own internal WiFi chipset. The firm thinks Qualcomm's (QCOM) long term prospects remain intact and it reiterates a Buy rating on the stock with an $86 price target.
<< 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | all recent news | >>

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use